×
0 0 0 0 0 -0.0369583636645703 -0.0566488060431757 -0.0620189266918863
Stockreport

Veracyte Announces Pivotal Clinical Validation Data for Afirma Genomic Sequencing Classifier Presented at World Congress on Thyroid Cancer

Veracyte, Inc (VCYT)  More Company Research Source: Business Wire
Last veracyte, inc earnings: 10/29 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF Enhanced Classifier Identifies 30% More Benign Patients Than Original, Flagship Test SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced today that an oral presentation of data from the pivotal clinical validation study of the Afirma Genomic Sequencing Classifier (GSC) was presented at the 3rd World Congress on Thyroid Cancer (WCTC) held July 27-30 in Boston, Mass. The data demonstrate that the test, a next-generation version of the company’s widely used Afirma Gene Expression Classifier (GEC), can identify 30 percent more benign thyroid nodules among those with “indeterminate” cytopathology – enabling these patients to avoid unnecessary diagnostic surgeries. “The Afirma GEC has already enabled nearly 30,000 patients to avoid unnecessary thyroid surgeries,” said Kepal N. Patel, MD, FACS, Chief, Division of Endocrine Surgery, NYU Langone Medical Center, who [Read more]

IMPACT SNAPSHOT EVENT TIME: VCYT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VCYT alerts
from News Quantified
Opt-in for
VCYT alerts

from News Quantified
Opt-in for
VCYT alerts

from News Quantified